Quest Diagnostics Inc. (DGX): Price and Financial Metrics

DGX POWR Grades

• DGX scores best on the Quality dimension, with a Quality rank ahead of 93.54% of US stocks.
• The strongest trend for DGX is in Quality, which has been heading up over the past 179 days.
• DGX's current lowest rank is in the Sentiment metric (where it is better than 16.91% of US stocks).

DGX Stock Summary

• Quest Diagnostics Inc's market capitalization of $16,889,711,486 is ahead of 86.04% of US-listed equities.
• With a price/earnings ratio of 8.47, Quest Diagnostics Inc P/E ratio is greater than that of about only 18.85% of stocks in our set with positive earnings.
• Quest Diagnostics Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 14.1%, greater than the shareholder yield of 88% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Quest Diagnostics Inc are SNX, IEX, ACGL, FIVE, and ALLE.
• DGX's SEC filings can be seen here. And to visit Quest Diagnostics Inc's official web site, go to www.questdiagnostics.com.

DGX Valuation Summary

• In comparison to the median Healthcare stock, DGX's EV/EBIT ratio is 75.09% lower, now standing at 7.3.
• Over the past 243 months, DGX's price/sales ratio has gone down 0.
• Over the past 243 months, DGX's price/sales ratio has gone down 0.

Below are key valuation metrics over time for DGX.

DGX Growth Metrics

The 5 year net income to common stockholders growth rate now stands at 5.73%.
• Its 5 year cash and equivalents growth rate is now at 167.19%.
• Its 5 year net cashflow from operations growth rate is now at 34.85%.

DGX's revenue has moved up $3,250,000,000 over the prior 34 months.

The table below shows DGX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	10,788	2,233	1,995
2021-09-30	11,046	2,293	2,184
2021-06-30	11,058	2,594	2,247
2021-03-31	10,335	2,489	1,801
2020-12-31	9,437	2,005	1,431
2020-09-30	8,361	1,812	1,105

DGX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• DGX has a Quality Grade of B, ranking ahead of 93.32% of graded US stocks.
• DGX's asset turnover comes in at 0.812 -- ranking 31st of 81 Healthcare stocks.
• SSY, LH, and BIOC are the stocks whose asset turnover ratios are most correlated with DGX.

The table below shows DGX's key quality metrics over time.